Transcript of Sakar Healthcare’s Q4 FY26 earnings call shows export growth in oncology and a rising oncology mix, with mixed domestic performance and guidance pointing to stronger FY27 exports across the pipeline.
AI Assistant
Sakar Healthcare Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.